"Novartis begins expansion of Singapore biopharmaceutical plant" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been ...

ProKidney Corp. has ended its pursuit of a high-profile 330-job, $458 million manufacturing plant in Greensboro by securing a ...

Addressing this lack of clarity by developing a single model that covers the continuum of digital maturity stages for a biopharmaceutical production plant was the task of the Digital Plant Maturity ...

Flexibility is the key to future of biopharmaceutical manufacturing. Production plants should be able to manufacture various product types and address a wide range of commercial volumes. To achieve ...

SEOUL, Dec. 5 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutical firm, said Thursday it has begun commercial operation of its third manufacturing plant in the country. The plant in ...

The Samsung Group unit will be the world's top biopharmaceutical contract manufacturing operator (CMO) once the new plant, the third for the company, becomes operational in 2018. "We will be the ...

Ho Chi Minh City is planning to invest close to $725 million to expand its High-Tech Park with the addition of a science and ...

Eli Lilly has said it is seeking permission to build a new biopharmaceutical manufacturing ... 445 million), and could create 300 jobs at the plant itself, with another 500 positions required ...

So Medicago, a clinical-stage biopharmaceutical company located in Quebec, Canada, is harnessing a plant-based transient expression process to produce pharmaceutical-grade proteins in a matter of ...

The students, faculty and researchers involved in biopharmaceutical sciences at the University take an interdisciplinary approach to addressing grand challenges of healthcare, medicine and ...